Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 10314
TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM50069756(CHEMBL3407547 | US11186587, Example ND-630 | US109...)
Affinity DataIC50: 0.5nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527539(US11186587, Example 22)
Affinity DataIC50: 0.630nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527001(US11186587, Example 4)
Affinity DataIC50: 0.680nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM526973(US11186587, Example 1)
Affinity DataIC50: 0.690nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527538(US11186587, Example 21)
Affinity DataIC50: 0.700nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527543(US11186587, Example 26)
Affinity DataIC50: 0.870nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527537(US11186587, Example 20)
Affinity DataIC50: 0.910nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM526976(US11186587, Example 3)
Affinity DataIC50: 1nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527016(US11186587, Example 8)
Affinity DataIC50: 1.12nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527069(US11186587, Example 12)
Affinity DataIC50: 1.22nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527058(US11186587, Example 10)
Affinity DataIC50: 1.35nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527545(US11186587, Example 28)
Affinity DataIC50: 1.48nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527542(US11186587, Example 25)
Affinity DataIC50: 1.57nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527094(US11186587, Example 14)
Affinity DataIC50: 1.69nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527050(US11186587, Example 9)
Affinity DataIC50: 2.03nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527546(US11186587, Example 29)
Affinity DataIC50: 2.13nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527015(US11186587, Example 7)
Affinity DataIC50: 2.23nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527076(US11186587, Example 13)
Affinity DataIC50: 2.33nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527006(US11186587, Example 6)
Affinity DataIC50: 2.81nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527541(4-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-...)
Affinity DataIC50: 3.06nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527001(US11186587, Example 4)
Affinity DataIC50: 3.16nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM50069756(CHEMBL3407547 | US11186587, Example ND-630 | US109...)
Affinity DataIC50: 3.56nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527067(US11186587, Example 11)
Affinity DataIC50: 4.5nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527541(4-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-...)
Affinity DataIC50: 5.12nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527539(US11186587, Example 22)
Affinity DataIC50: 5.13nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM526973(US11186587, Example 1)
Affinity DataIC50: 5.13nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527058(US11186587, Example 10)
Affinity DataIC50: 6.85nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527123(US11186587, Example 16)
Affinity DataIC50: 6.89nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527542(US11186587, Example 25)
Affinity DataIC50: 7.57nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527140(US11186587, Example 17)
Affinity DataIC50: 7.66nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527545(US11186587, Example 28)
Affinity DataIC50: 7.80nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527094(US11186587, Example 14)
Affinity DataIC50: 7.85nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527050(US11186587, Example 9)
Affinity DataIC50: 7.92nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527547(US11186587, Example 30)
Affinity DataIC50: 7.97nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527537(US11186587, Example 20)
Affinity DataIC50: 8.03nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527069(US11186587, Example 12)
Affinity DataIC50: 8.04nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM526974(US11186587, Example 2)
Affinity DataIC50: 8.70nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527122(US11186587, Example 15)
Affinity DataIC50: 8.79nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527006(US11186587, Example 6)
Affinity DataIC50: 9.64nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527543(US11186587, Example 26)
Affinity DataIC50: 10.3nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527540(US11186587, Example 23)
Affinity DataIC50: 11.5nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527076(US11186587, Example 13)
Affinity DataIC50: 11.6nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527544(US11186587, Example 27)
Affinity DataIC50: 11.8nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM526976(US11186587, Example 3)
Affinity DataIC50: 11.9nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527015(US11186587, Example 7)
Affinity DataIC50: 12.4nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527016(US11186587, Example 8)
Affinity DataIC50: 13.1nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 2(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527546(US11186587, Example 29)
Affinity DataIC50: 14.1nMAssay Description:4.5 μL of 2.2×ACC2 enzyme (1.1 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527256(US11186587, Example 19)
Affinity DataIC50: 23.3nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527005(US11186587, Example 5)
Affinity DataIC50: 38.5nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

TargetAcetyl-CoA carboxylase 1(Human)
Nanjing Sanhome Pharmaceutical

US Patent
LigandPNGBDBM527548(US11186587, Example 31)
Affinity DataIC50: 136nMAssay Description:4.5 μL of 2.2×ACC1 enzyme (2 nM) working solution was added to a 384-well plate; and then 0.5 μL of different concentrations of compound we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
US Patent

Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: